Amlodipine
氨氯地平
Report date: 2026/03/24 20:00:35
Base Information
Drug NameAmlodipine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesBrillian Pharma IncWeill Medical College of Cornell UniversityUniversity Of Rochester +[6]
Active Indications +[7]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A